Millions of patients depend on a rare radioactive form of one element to scan them for disease. But the old nuclear reactors that make it are shutting down
Researchers are concerned that the syndrome may be due to drug contamination
In the past three months there have been multiple outbreaks in Europe, Africa and Asia
Blood tests can be highly unreliable
Sunscreen or beach umbrellas alone were unable to completely prevent sunburns—so researchers suggest combining the methods instead. Christopher Intagliata reports.
But dropping the appeal of a lawsuit would immediately end cost-sharing help for up to six million people and would almost certainly send the insurance market for individuals into chaos...
Funnel web venom needed after a dry spell triggers more bites
Marchers worry that the president's rhetoric and nominee choices threaten research, the scientific method and reproductive rights
The 45th president may still name a different permanent director
Scientific American executive editor Fred Guterl talks with Pres. Obama’s science advisor, John Holdren, about climate science, space travel, the issue of reproducibility in science, the brain initiative and more...
Public officials are advancing measures, such as more blood-lead screening and property inspections, to protect children from the toxic threat
Early targets include Nipah virus and Middle East respiratory syndrome
Committee mentioned in a Trump meeting last week could scare people away from protective immunizations, scientists say
The nation’s public health agency is battling on several fronts, including an Obamacare repeal
Pulitzer Prize–winning N.Y.U. historian David Oshinsky, director of the Division of Medical Humanities at the N.Y.U. Langone Medical Center, talks about his latest book, Bellevue: Three Centuries of Medicine and Mayhem at America’s Most Storied Hospital ...
More than one third of all injuries on the pitch occurred during practice
Rep. Tom Price can expect some tough questions from his Senate interrogators
The Trump administration may not be as supportive as Obama was of successful “ANGEL” programs
The “nightmare bacteria” could fend off 26 different drugs
The agency's current director has said he would be willing to stay